ZEISS to acquire LENSO Sp. z o.o. to strengthen market access and industry expertise in 3D metrology and inspection solutions in Poland

16-Jan-2023 - ZEISS plans to expand its market presence in Poland for its Industrial Quality & Research segment by acquiring LENSO. The company will become part of ZEISS Industrial Quality Solutions. Headquartered in Poznan, Poland, LENSO is the leading partner in Poland for 3D optical systems. With this ...

ExPLoRNA Therapeutics receives funding to advance its novel mRNA technology

14-Dec-2022 - ExPLoRNA Therapeutics, a Polish biotech company revolutionizing mRNA vaccines and therapeutics with unprecedented translational efficiency, received funding from the Bill & Melinda Gates Foundation to further develop its unique mRNA technology. ExPLoRNA specializes in novel cap analogs, the ...

BioNTech and Ryvu Therapeutics enter partnership

Research collaboration for several small molecule immunotherapy programs

02-Dec-2022 - BioNTech SE and Ryvu Therapeutics S.A., a clinical-stage company developing oncology therapeutics announced that the companies have entered into a multi-target research collaboration for several small molecule immunotherapy programs as well as an exclusive license agreement for Ryvu’s STING ...

H3 Biomedicine and Selvita Reach First Research Milestone in Precision Cancer Medicines Collaboration

Companies Advance Multiple Co-discovery Programs for First-in-class Targets in Oncology

27-May-2014 - H3 Biomedicine Inc. and Selvita announced that they have achieved the first research milestone in their strategic collaboration to develop breakthrough precision medicines for cancers. The companies have validated the importance and druggability of a kinase target in a specific genetic context ...

Selvita and Orion Pharma Achieve a Research Milestone in Alzheimer’s Disease Program

03-Jul-2012 - Selvita S.A. announced that its collaboration with Orion Corporationon SEL103 program, for the symptomatic treatment of Alzheimer’s disease has reached the main research milestone and that the jointly discovered molecules from two different chemical families will progress into further ...

Selvita And Orion Pharma Will Collaborate on SEL103 - Alzheimer’s Disease Program

09-Jul-2010 - Selvita sp. z o.o. and Orion Corporation from Espoo, Finland announced that they have entered into a global collaboration to jointly develop and commercialize SEL103, Selvita’s proprietary program for the treatment of Alzheimer’s disease and other cognitive disorders. Selvita will be responsible ...

Government Initiatives to Encourage Adoption of Healthcare IT Solutions in Poland, Finds Frost & Sullivan

22-Apr-2010 - Various initiatives by the Polish Government, coupled with funding from the European Union (EU), have been driving the adoption of IT systems by the healthcare sector. The acceptance of the Euro as Poland’s currency is set to further fuel IT funding by the EU in the country. New analysis from ...